1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with sq 26536 in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (sq 26536) | Trials (sq 26536) | Recent Studies (post-2010) (sq 26536) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 15 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dangelmaier, C; Selak, M; Smith, JB | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and sq 26536
Article | Year |
---|---|
Identification of 50 kDa snake venom proteins which specifically inhibit platelet adhesion to collagen.
Topics: Adenosine Diphosphate; Animals; Blotting, Western; Collagen; Epinephrine; Fatty Acids, Monounsaturated; Humans; In Vitro Techniques; Kinetics; Molecular Weight; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Snake Venoms; Snakes; Species Specificity | 1991 |